Henrik Maagensen

3PUBLICATIONS
6CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 12, 2026
Empagliflozin in HNF1A-MODY (MODY3): A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Henrik Maagensen, Stine O Høyerup, Johanne S Jensen

|Jul 03, 2025
Effect of SGLT2 Inhibition on Glucosuria During a Hyperglycemic Clamp in HNF1A-MODY (MODY3) and Type 2 Diabetes.

Henrik Maagensen, Johanne S Jensen, Stine O Høyerup

|Jun 14, 2024
Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3).

Henrik Maagensen, Sofie Hædersdal, Jesper Krogh

Pageof 1